Ametris employee Sean Smith will attend DPharm 2026 in Boston next month.

At Ametris, we partner with life sciences organizations to transform complex, real-world patient data into evidence that drives progress. Our end-to-end DHT platform integrates advanced wearable technologies, expert scientific consultation, and regulatory-aligned analytics to support every phase of a clinical trial. From initial study design through submission, we simplify digital implementation and ensure that data serves its highest purpose: informing better science and improving lives.